Overview
Xiaoyang Zhai practices in Jinan, China. Zhai is rated as an Advanced expert by MediFind in the treatment of Small Cell Lung Cancer (SCLC). Their top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Pneumonia.
Their clinical research consists of co-authoring 24 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 6 articles in the study of Small Cell Lung Cancer (SCLC).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Small Cell Lung Cancer (SCLC)
- Experienced
- Brain TumorZhai isExperienced. Learn about Brain Tumor.
- Lung AdenocarcinomaZhai isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerZhai isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- PneumoniaZhai isExperienced. Learn about Pneumonia.